Developing proprietary systems for global-scale
de novo designs

We’re exploring the frontiers of modern biotechnology through fast innovation, AI-driven discoveries, and virtual high-throughput systems. Join KaiGenesis to transform legacy methods of discovering life-changing therapeutics.
backed by angel investors

Growth Far Beyond Expectations

January 2026

KaiGenesis Founding Vision

Our journey began with a few ideas exchanged between former colleagues.

March 2026

Official Launch

We introduced our science to experienced researchers for feedback.

May 2026

MVP and Partnering

Our technologies passed validation and successfully secured core funding.

August 2026

Scaling Products and Assets

High-impact scaling in preparation for regional breakthroughs.

November 2026

Expansion and IP Protection

Upcoming plans for industry-wide recognition.


Technologies created for all — from chemistry education platforms to bleeding-edge in-silico discovery in unexplored synthetic configurations.

We’re building tools to advance computational chemistry, therapeutics, and AI-aided, synthetic discoveries — and we’re doing it for the public, faster than ever before.

KaiGenesis SDK

The developer and enterprise bedrock. A robust, high-performance framework designed for the heavy lifting of multi-scale cheminformatics. It powers seamless 3D-preservation workflows that move structural files without ever degrading structural data.

MirrorSuite

Our flagship enterprise pipeline focused on structure-based drug design for next-generation biological therapeutics. MirrorSuite specializes in mapping mirror-image proteins, synthetic peptides, and complex macrocyclic systems.

KaiGenesis Discovery Tools

Our commitment to global scientific literacy and accessible innovation. Discover is a free, interactive, web-based molecular workbench that integrates 2D sketching, real-time 3D rendering, a fast peptide builder, and local AI assistance into a single unified app.

Our Assets

KaiGenesis Labs offers a unique decentralized open-science framework allowing researchers, startups, and global organizations to permanently mint newly discovered molecules, distinct-energy variants, and de novo structures on the blockchain as unique digital IP assets. These verifiably unique synthetic creations embed complete 3D structural data files, cryptographic proofs of novelty, and immutable audit trails of the entire discovery and quantum validation process to establish immediate, transparent, and legally defensible ownership.

What Are We Doing Differently?

Created as lightweight, highly scalable platforms built from the ground up via our V5 engine and flexible SDK, we’re designing modular tools that can scale with every new release, update, and innovation that emerges.

How We Can Help Your Efforts Today

We provide structurally intact 3D datasets as well as data-rich files for hard-to-find stereoisomers and de novo molecules.
Publication-ready In-silico data
Virtual High-Throughput Screening and Hit Selection
Best Available Candidates and Data for All Stereoisomers

A cut above the rest at a fraction of the cost

Our forge produces data on the fly and with the quality available due to our custom engine, we’re finding promising hits at an accelerated pace.
0
Unique datasets
0
New hits
0
Molecules screened